Cargando…

Lipschütz ulceration in a 12-year-old girl following second dose of Comirnaty (Pfizer) COVID-19 vaccine

Detalles Bibliográficos
Autores principales:	Frederiks, Aaron J., Foster, Rachael S., Ricciardo, Bernadette
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Case Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746224/ https://www.ncbi.nlm.nih.gov/pubmed/36531266 http://dx.doi.org/10.1097/JW9.0000000000000066

Ejemplares similares

Acute genital ulcers in a young girl: a clinical challenge: Lipschütz ulcer()
por: Schafer, Fabiola, et al.
Publicado: (2022)

Respiratory Pathogen Evaluation for Lipschütz Ulcer
por: Limperg, Tobias, et al.
Publicado: (2018)

Lipschütz Ulcers: Classic Presentation of an Uncommon Condition
por: Gay, Carter, et al.
Publicado: (2023)

Lipschütz Ulcer: An Unusual Diagnosis that Should Not be Neglected
por: Pereira, Daniela Alexandra Gonçalves, et al.
Publicado: (2021)

Ulcer of Lipschutz, a rare and unknown cause of genital ulceration
por: Moise, A, et al.
Publicado: (2018)

Lipschütz ulcers after AstraZeneca COVID-19 vaccination()
por: Bracho-Borro, Maria, et al.
Publicado: (2023)

Lipschütz Genital Ulceration as Initial Manifestation of Primary Sjögren's Syndrome
por: de Castro Coelho, Filipa, et al.
Publicado: (2018)

Lipschütz's ulcers in an adolescent with SARS‐CoV2 infection
por: Morais, Mariana Lira, et al.
Publicado: (2022)

[Translated article] Lipschütz Ulcers After the AstraZeneca COVID-19 Vaccine
por: González-Romero, N., et al.
Publicado: (2022)

Menstrual disturbances in 12- to 15-year-old girls after one dose of COVID-19 Comirnaty vaccine: Population-based cohort study in Norway
por: Caspersen, Ida Henriette, et al.
Publicado: (2023)

Lipschutz Ulcers in an Adolescent After Sars-CoV-2 Infection
por: Schmitt, Tonya M., et al.
Publicado: (2023)

Ulcère de Lipschütz: une cause rare et sous diagnostiquée d'ulcération génitale
por: Raffas, Wafae, et al.
Publicado: (2013)

Lipschütz Ulcer and SARS-CoV-2: What We Currently Know?
por: Merlino, Lucia, et al.
Publicado: (2023)

COVID-19, Coronavirus Vaccines, and Possible Association with Lipschütz Vulvar Ulcer: A Systematic Review
por: Vismara, Stefano A., et al.
Publicado: (2023)

Érythème pigmenté fixe après vaccin anti-COVID-19 Comirnaty® de Pfizer/BioNTech
por: Lellig, Elodie, et al.
Publicado: (2021)

Subacute monomelic radiculoplexus neuropathy following Comirnaty© (Pfizer-BioNTech COVID-19) vaccination: A case report
por: Coly, M., et al.
Publicado: (2023)

Pruritus as an early sign of abnormal scarring in the re‐epithelialising phase of Toxic Epidermal Necrolysis
por: Frederiks, Aaron J., et al.
Publicado: (2023)

Analysing the In-Use Stability of mRNA-LNP COVID-19 Vaccines Comirnaty™ (Pfizer) and Spikevax™ (Moderna): A Comparative Study of the Particulate
por: Hermosilla, Jesús, et al.
Publicado: (2023)

Effusive–constrictive pericarditis after the second dose of BNT162b2 vaccine (Comirnaty): a case report
por: Viani, Giacomo Maria, et al.
Publicado: (2022)

Immune thrombocytopaenic purpura following the second dose of Pfizer COVID-19 vaccine
por: Latef, Taroob, et al.
Publicado: (2022)

No safety concerns with Comirnaty vaccine in pregnancy
Publicado: (2021)

Self-reported reactogenicity of CoronaVac (Sinovac) compared with Comirnaty (Pfizer-BioNTech): A prospective cohort study with intensive monitoring
por: Lai, Francisco Tsz Tsun, et al.
Publicado: (2022)

Histopathologically TMA-like distribution of multiple organ thromboses following the initial dose of the BNT162b2 mRNA vaccine (Comirnaty, Pfizer/BioNTech): an autopsy case report
por: Kaimori, Ryo, et al.
Publicado: (2022)

SARS-CoV-2 neutralizing antibodies after one or two doses of Comirnaty (BNT162b2, BioNTech/Pfizer): Kinetics and comparison with chemiluminescent assays
por: Padoan, Andrea, et al.
Publicado: (2021)

Status migrainosus: a potential adverse reaction to Comirnaty (BNT162b2, BioNtech/Pfizer) COVID-19 vaccine—a case report
por: Consoli, Stefano, et al.
Publicado: (2021)

Comparison of medium-term adverse reactions induced by the first and second dose of mRNA BNT162b2 (Comirnaty, Pfizer-BioNTech) vaccine: a post-marketing Italian study conducted between 1 January and 28 February 2021
por: Ossato, Andrea, et al.
Publicado: (2023)

Revision of Comirnaty precautions in Japan
Publicado: (2022)

Pityriasis Rosea Following Pfizer-BioNTech Vaccination in an Adolescent Girl
por: Bin Rubaian, Nouf F, et al.
Publicado: (2022)

Acute asthma exacerbation due to the SARS-CoV-2 vaccine (Pfizer-BioNTech BNT162b2 messenger RNA COVID-19 vaccine [Comirnaty(Ⓡ)])
por: Ando, Masaru, et al.
Publicado: (2022)

Stevens-Johnson syndrome post second dose of Pfizer COVID-19 vaccine: a case report
por: Elboraey, Mohamed Omar, et al.
Publicado: (2021)

The usability of testing skin reaction applying skin prick tests with Comirnaty (Pfizer, USA) vaccine in detecting the risk of developing post-vaccination immediate hypersensitivity response (anaphylaxis) after administration of this vaccine
por: Gulas, Ewelina, et al.
Publicado: (2023)

Prior COVID-19 infection is associated with increased Adverse Events (AEs) after the first, but not the second, dose of the BNT162b2/Pfizer vaccine
por: Raw, Rachael K., et al.
Publicado: (2022)

Active Surveillance of Adverse Events in Healthcare Workers Recipients After Vaccination with COVID-19 BNT162b2 Vaccine (Pfizer-BioNTech, Comirnaty): A Cross-Sectional Study
por: Ripabelli, Giancarlo, et al.
Publicado: (2021)

Ulcus vulvae acutum Lipschütz: a systematic literature review and a diagnostic and therapeutic algorithm
por: Sadoghi, B., et al.
Publicado: (2020)

The SARS-CoV-2 spike residues 616/644 and 1138/1169 delineate two antibody epitopes in COVID-19 mRNA COMIRNATY vaccine (Pfizer/BioNTech)
por: Andries, Jessica, et al.
Publicado: (2022)

Early tolerability of Comirnaty vaccine in patients with chronic neurological diseases
por: Budowski, C., et al.
Publicado: (2021)

Antibody dynamics post-Comirnaty and CoronaVac vaccination in Malaysia
por: Tan, Cheng Siang, et al.
Publicado: (2022)

Adverse reactions to the first and second doses of Pfizer-BioNTech COVID-19 vaccine among healthcare workers
por: Maruyama, Ayano, et al.
Publicado: (2022)

A 12-Month-Old Healthy Girl with a New Oral Ulcer and Chronic Diaper Rash
por: Song, Hannah, et al.
Publicado: (2017)

First Identified Case of Fatal Fulminant Necrotizing Eosinophilic Myocarditis Following the Initial Dose of the Pfizer-BioNTech mRNA COVID-19 Vaccine (BNT162b2, Comirnaty): an Extremely Rare Idiosyncratic Hypersensitivity Reaction
por: Ameratunga, Rohan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kio9r2b1nckrna53l3c9fijde4